ArticleAntiviral research2022

Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides.

Yuanmei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.